TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10586011

Group type: EXPERIMENTAL
Intervention: Systemic prednisolone mixture 2 mg/kg daily for 5 days
Number of subjects: 147

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 147
Study: 8952213

Group type: EXPERIMENTAL
Intervention: Drink driving education program
Number of subjects: 1774
Study: 1931705

Group type: EXPERIMENTAL
Intervention: Interferon alfa-2b (IFN alpha-2b) at 1.5 MU/d
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Interferon alfa-2b (IFN alpha-2b) at 1.5 MU three times a week
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Interferon alfa-2b (IFN alpha-2b) at 3.0 MU three times a week
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Interferon alfa-2b (IFN alpha-2b) with reduced doses
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 34
Study: 6277355

Group type: EXPERIMENTAL
Intervention: 2.5 mg delta 9THC
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 10 mg delta 9THC
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 9 mg delta 9THC
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: delta 9THC
Number of subjects: 20
Study: 31186121

Group type: EXPERIMENTAL
Intervention: 7-day ibuprofen (600 mg three times a day)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: 3-day ibuprofen (600 mg three times a day for 3 days, then placebo for 4 days)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo (for 7 days)
Number of subjects: 95
Study: 27206464

Group type: EXPERIMENTAL
Intervention: Direct Mail plus Incentive
Number of subjects: 18939

Group type: EXPERIMENTAL
Intervention: Direct Mail only
Number of subjects: 18939

Group type: COMPARATOR
Intervention: Control
Number of subjects: 18939
Study: 25873553

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (150,000 IU ergocalciferol every 3 months)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 23686032

Group type: EXPERIMENTAL
Intervention: Self-awareness assessed with the Beck Cognitive Insight Scale and patient-caregiver discrepancy scores from the Dysexecutive Questionnaire and the Everyday Memory Questionnaire-Revised
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Neuropsychological functioning measures
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Motor complications of PD therapy
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Antidepressant medication
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Dopaminergic medication profiles
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Awareness of impulsivity
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Executive dysfunction
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Awareness of inability to resist motivated behaviors
Number of subjects: 34
Study: 21075774

Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy with defibrillator (CRT-D)
Number of subjects: 1820
Study: 19121446

Group type: EXPERIMENTAL
Intervention: Beta blocker alone
Number of subjects: 1269

Group type: EXPERIMENTAL
Intervention: Beta blocker plus digoxin
Number of subjects: 1269

Group type: COMPARATOR
Intervention: Digoxin alone
Number of subjects: 1269

Group type: COMPARATOR
Intervention: Control group (no beta blocker or digoxin)
Number of subjects: 1269
Study: 17224434

Group type: EXPERIMENTAL
Intervention: Precooling (PC) - wearing a cooling vest (0 degrees C‐5 degrees C) for 20 min at rest
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Warm-up (WU) - 20 min at 70% maximum heart rate (HR)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (C) - no particular preparation
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Precooling (PC)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Warm-up (WU)
Number of subjects: 20
Study: 15196774

Group type: EXPERIMENTAL
Intervention: Biotin-glutamic acid decarboxylase 65 (GAD65)-based enzyme-linked immunosorbent assay (B-ELISA)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Healthy control group
Number of subjects: 78
Study: 11310708

Group type: COMPARATOR
Intervention: Levodopa alone
Number of subjects: 72

Group type: COMPARATOR
Intervention: Levodopa and part‐time occlusion (3 hours/day)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Levodopa and full‐time occlusion (during all waking hours)
Number of subjects: 72
Study: 9135194

Group type: EXPERIMENTAL
Intervention: Clonidine (5 micrograms.kg‐1) administered orally 90 min before surgery
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (no premedication)
Number of subjects: 42
Study: 7835807

Group type: EXPERIMENTAL
Intervention: Ovarian cancer screening
Number of subjects: 74000

Group type: EXPERIMENTAL
Intervention: New screening programs for women with a family history of ovarian cancer
Number of subjects: 74000
Study: 2405613

Group type: EXPERIMENTAL
Intervention: Nicardipine (60-90 mg/day)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Nicardipine (30-90 mg/day)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Nicardipine (mean dose 69.4 mg/day)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Nicardipine (60 mg/day)
Number of subjects: 105
Study: 31688431

Group type: EXPERIMENTAL
Intervention: Oral bicarbonate on top of hydration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous bicarbonate on top of hydration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hydration alone
Number of subjects: 0
Study: 29655859

Group type: EXPERIMENTAL
Intervention: Working memory training and distress tolerance (mindfulness) interventions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard smoking prevention informational intervention
Number of subjects: 0
Study: 28472528

Group type: EXPERIMENTAL
Intervention: Internet Cognitive Behavioral Therapy for insomnia (CBTi)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: In-Person Cognitive Behavioral Therapy for insomnia (CBTi)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control condition (phone call assessments)
Number of subjects: 100
Study: 26477761

Group type: EXPERIMENTAL
Intervention: Bu+Mel+Flu+Ara‐C (BMFA)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Bu+Cy+Flu+Ara‐C (BCFA)
Number of subjects: 94
Study: 24521895

Group type: EXPERIMENTAL
Intervention: Trial group (n = 24) received solifenacin succinate (5 mg, once a day) and naftopidil (25 mg, every evening)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group I (n = 22) received only solifenacin succinate
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group II (n = 21) received only naftopidil
Number of subjects: 67
Study: 22041323

Group type: EXPERIMENTAL
Intervention: Atorvastatin (10 mg)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 18081771

Group type: EXPERIMENTAL
Intervention: Gold alloy tip electrodes
Number of subjects: 252

Group type: COMPARATOR
Intervention: Standard platinum-iridium (Pt-Ir) catheters
Number of subjects: 252
Study: 16949486

Group type: EXPERIMENTAL
Intervention: Metformin 500 mg twice a day (n = 16)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo (n = 17)
Number of subjects: 33
Study: 14563591

Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy (CRT)
Number of subjects: 490

Group type: COMPARATOR
Intervention: Control (no CRT)
Number of subjects: 490
Study: 10823767

Group type: EXPERIMENTAL
Intervention: Oral inactivated whole cell Vibrio cholerae plus recombinant B subunit cholera vaccine
Number of subjects: 17799

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17799
Study: 8857279

Group type: EXPERIMENTAL
Intervention: Vibration + noise + tool weight
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vibration alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 2001053

Group type: EXPERIMENTAL
Intervention: CPAP-5
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: PS-5
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: CPAP-0
Number of subjects: 10

Group type: COMPARATOR
Intervention: T-piece
Number of subjects: 10
Study: 6441194

Group type: EXPERIMENTAL
Intervention: Fast neutron irradiation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mega-voltage X‐rays
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Photons (subgroup treatment for larynx cancer)
Number of subjects: 0
Study: 30677636

Group type: EXPERIMENTAL
Intervention: Interrupted suturing with injected local anaesthetic and Vicryl Rapide 3.0 or equivalent
Number of subjects: 22

Group type: COMPARATOR
Intervention: Continuous or subcuticular sutures
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Graze (unilateral or bilateral vertical skin separation with minimal trauma)
Number of subjects: 22
Study: 29382142

Group type: EXPERIMENTAL
Intervention: Fructose (F)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Glucose (G)
Number of subjects: 8
Study: 26841341

Group type: EXPERIMENTAL
Intervention: Routine weighing in the antenatal clinic
Number of subjects: 782

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 782

Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 782
Study: 25378376

Group type: EXPERIMENTAL
Intervention: Oral hydration
Number of subjects: 225

Group type: COMPARATOR
Intervention: IV hydration
Number of subjects: 225

Group type: COMPARATOR
Intervention: Comparison of both groups
Number of subjects: 225
Study: 22702892

Group type: EXPERIMENTAL
Intervention: Unilateral pedicle screw and 1 cage
Number of subjects: 50

Group type: COMPARATOR
Intervention: Bilateral pedicle screws and 2 cages
Number of subjects: 50
Study: 20185972

Group type: EXPERIMENTAL
Intervention: Multicomponent psychological intervention
Number of subjects: 52

Group type: COMPARATOR
Intervention: Standard medical care (Control)
Number of subjects: 52
Study: 18361754

Group type: EXPERIMENTAL
Intervention: Pickles (PCK) (approximately 1,400 mg of acetic acid daily)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Vinegar (VIN) (2,800 mg of acetic acid daily)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Commercial vinegar pills (REF) (30 mg of acetic acid daily)
Number of subjects: 27
Study: 15994575

Group type: EXPERIMENTAL
Intervention: Self-help booklet (n=75)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Control group (n=67)
Number of subjects: 142
Study: 12766653

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.2% with 30 mg of ketorolac
Number of subjects: 10

Group type: COMPARATOR
Intervention: Ropivacaine 0.2% with normal saline
Number of subjects: 10
Study: 9664951

Group type: EXPERIMENTAL
Intervention: Anti-thymocyte globulin (ATG) - 7 x 4 mg/kg body weight i.v.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Methylprednisolone (MP) - 3 x 250 mg i.v.
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups (ATG and MP)
Number of subjects: 50
Study: 7706148

Group type: EXPERIMENTAL
Intervention: Teaching children to ask the question 'What's that?'
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Acquisition of novel information through asking questions
Number of subjects: 3
Study: 2785355

Group type: EXPERIMENTAL
Intervention: Continuous intravenous infusion of propofol, 18 mg.kg‐1.h‐1 for the first 30 min and 15 mg.kg‐1.h‐1 thereafter
Number of subjects: 42

Group type: COMPARATOR
Intervention: 2.5% enflurane, then 2% enflurane after 30 min
Number of subjects: 42
Study: 959762

Group type: COMPARATOR
Intervention: Control perfusate
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Dihydroxy bile acids
Number of subjects: 11
Study: 29128650

Group type: EXPERIMENTAL
Intervention: 8-month social marketing campaign delivered by child care centers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 8-month social marketing campaign
Number of subjects: 0
Study: 28946866

Group type: EXPERIMENTAL
Intervention: Micronutrient powders (MNPs) given daily to caregivers of infants in the treatment group.
Number of subjects: 1802

Group type: COMPARATOR
Intervention: Control group (no MNPs provided).
Number of subjects: 1802
Study: 25704725

Group type: EXPERIMENTAL
Intervention: Lottery arm (a € 1 lottery scratch card sent with the questionnaire)
Number of subjects: 4820

Group type: COMPARATOR
Intervention: Prize arm (entry into a draw on return of a completed questionnaire)
Number of subjects: 4820

Group type: EXPERIMENTAL
Intervention: Lottery arm (long-term survivors)
Number of subjects: 4820

Group type: EXPERIMENTAL
Intervention: Cost per completed questionnaire
Number of subjects: 4820
Study: 23945720

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (25 mg Zn/d)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 20598480

Group type: EXPERIMENTAL
Intervention: Percutaneous treatment with ePTFE/nitinol self-expanding stent graft (n = 50)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Surgical treatment with femoral to above-knee popliteal artery bypass using synthetic conduit (n = 50)
Number of subjects: 86
Study: 18067598

Group type: EXPERIMENTAL
Intervention: SLA implants
Number of subjects: 32

Group type: COMPARATOR
Intervention: TPS implants
Number of subjects: 32
Study: 16697124

Group type: EXPERIMENTAL
Intervention: Propranolol (100 mg/day)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Amantadine (300 mg/day)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Combination of amantadine (300 mg/day) and propranolol (100 mg/day)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 199
Study: 12743863

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) using the photosensitizer SQN 400 and interstitial photodynamic laser treatment
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Combined use of several fibres for tumor ablation
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Photodynamic laser therapy
Number of subjects: 5
Study: 11302998

Group type: EXPERIMENTAL
Intervention: Low dose insulin infusion
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: High dose insulin infusion
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 9039246

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 500 micrograms
Number of subjects: 12

Group type: COMPARATOR
Intervention: Budesonide 500 micrograms
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 1000 micrograms
Number of subjects: 12

Group type: COMPARATOR
Intervention: Budesonide 1000 micrograms
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 2000 micrograms
Number of subjects: 12

Group type: COMPARATOR
Intervention: Budesonide 2000 micrograms
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 7908410

Group type: EXPERIMENTAL
Intervention: High-dose adjuvant chemotherapy (cyclophosphamide, doxorubicin, and fluorouracil)
Number of subjects: 442

Group type: COMPARATOR
Intervention: Moderate-dose and low-dose adjuvant chemotherapy (cyclophosphamide, doxorubicin, and fluorouracil)
Number of subjects: 442
Study: 3265525

Group type: EXPERIMENTAL
Intervention: 60 mg fluoxetine
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 50 mg amitriptyline
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 5 mg diazepam
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 50 mg amitriptyline + 5 mg diazepam
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo + 5 mg diazepam
Number of subjects: 90
Study: 1887747

Group type: EXPERIMENTAL
Intervention: Laryngoscopy with orotracheal intubation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Laryngoscopy without orotracheal intubation
Number of subjects: 40
Study: 332196

Group type: EXPERIMENTAL
Intervention: Cycloalliin, single oral dosage
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 18
Study: 30278197

Group type: EXPERIMENTAL
Intervention: Selective Laser Trabeculoplasty (SLT)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Argon Laser Trabeculoplasty (ALT)
Number of subjects: 130
Study: 28199736

Group type: EXPERIMENTAL
Intervention: Oral contraceptive pills (OCP)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Lifestyle (intensive Lifestyle modification)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Combined (OCP + Lifestyle)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: OCP
Number of subjects: 87

Group type: COMPARATOR
Intervention: Lifestyle and Combined groups
Number of subjects: 87
Study: 25675384

Group type: EXPERIMENTAL
Intervention: RM-493 (1 mg/24 h)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 24015415

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 90

Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 90
Study: 22397264

Group type: EXPERIMENTAL
Intervention: Food supplement containing D‐phenylalanine, L‐glutamine and L‐5‐hydroxytriptophan
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 19715914

Group type: COMPARATOR
Intervention: Sirolimus with Cyclosporine and Steroids (SRL-CsA-ST)
Number of subjects: 525

Group type: EXPERIMENTAL
Intervention: Sirolimus with Steroids after Cyclosporine withdrawal (SRL-ST)
Number of subjects: 525

Group type: EXPERIMENTAL
Intervention: Both groups (SRL-CsA-ST and SRL-ST)
Number of subjects: 525

Group type: COMPARATOR
Intervention: SRL-CsA-ST
Number of subjects: 525

Group type: EXPERIMENTAL
Intervention: SRL-ST
Number of subjects: 525
Study: 18236765

Group type: EXPERIMENTAL
Intervention: Jiawei simiaosan combined with the external application of Sihuangshuimi
Number of subjects: 65

Group type: COMPARATOR
Intervention: Gout treatment with colchicine
Number of subjects: 65
Study: 14685854

Group type: EXPERIMENTAL
Intervention: Contiguity and contingency manipulation of key presses and subsequent tones
Number of subjects: 0
Study: 11581559

Group type: EXPERIMENTAL
Intervention: Eccentric training (ET) group performed 30 repetitions of maximal voluntary isokinetic eccentric contraction (ECC1) on nondominant elbow flexors with Cybex 6000 at 60 degrees.s‐1 angular velocity for 7 consecutive days (ECC2 to ECC7).
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (CON) did not perform the eccentric training.
Number of subjects: 22
Study: 9886905

Group type: EXPERIMENTAL
Intervention: Nifedipine GITS 30 mg daily
Number of subjects: 6450

Group type: COMPARATOR
Intervention: Co-amilozide (hydrochlorothiazide 25 mg/amiloride 5 mg) once daily
Number of subjects: 6450
Study: 8057222

Group type: EXPERIMENTAL
Intervention: 20 mg Zn++ as sulfate daily
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: 40 mg Zn++ as sulfate daily
Number of subjects: 200

Group type: COMPARATOR
Intervention: 0 mg Zn++ as sulfate daily (control)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Low zinc intake (about one-tenth of RDA)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Infants with highest rates of growth
Number of subjects: 200
Study: 2736749

Group type: EXPERIMENTAL
Intervention: Early angiography (17 +/- 6 hours)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Late angiography (5.7 +/- 2.1 days)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Late elective angiography
Number of subjects: 78

Group type: COMPARATOR
Intervention: Late urgent angiography
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Patients with coronary thrombus
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Patients with complex coronary morphology
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Patients with multiple-vessel disease
Number of subjects: 78

Group type: COMPARATOR
Intervention: Patients without angiographic features
Number of subjects: 78

Group type: COMPARATOR
Intervention: Patients without complex coronary morphology
Number of subjects: 78

Group type: COMPARATOR
Intervention: Patients without multiple-vessel disease
Number of subjects: 78
Study: 31147827

Group type: EXPERIMENTAL
Intervention: Three-step etch-and-rinse (3-ER)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Two-step etch-and-rinse (2-ER)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Two-step self-etch (2-SE)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: One-step self-etch (1-SE)
Number of subjects: 39
Study: 29688617

Group type: EXPERIMENTAL
Intervention: Upadacitinib extended-release (ER) formulation 15 mg once daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Upadacitinib extended-release (ER) formulation 30 mg once daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Upadacitinib extended-release (ER) formulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: High-fat breakfast
Number of subjects: 0
Study: 27100393

Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with extra-virgin olive oil or nuts
Number of subjects: 1139

Group type: COMPARATOR
Intervention: Low-fat control diet
Number of subjects: 1139

Group type: EXPERIMENTAL
Intervention: Increasing urinary TPE
Number of subjects: 1139
Study: 26208685

Group type: EXPERIMENTAL
Intervention: Abluminal groove-filled biodegradable polymer sirolimus-eluting stent (SES)
Number of subjects: 458

Group type: COMPARATOR
Intervention: Durable polymer everolimus-eluting stent (EES)
Number of subjects: 458
Study: 24298784

Group type: EXPERIMENTAL
Intervention: Abdominal acupuncture
Number of subjects: 157

Group type: COMPARATOR
Intervention: Body acupuncture
Number of subjects: 157
Study: 22900449

Group type: EXPERIMENTAL
Intervention: Atomized administration of intranasal ketamine (INK)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Drops administration of intranasal ketamine (INK)
Number of subjects: 34
Study: 19455040

Group type: EXPERIMENTAL
Intervention: sugammadex 2.0 mg/kg
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: sugammadex 4.0 mg/kg
Number of subjects: 116

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 116
Study: 16477334

Group type: EXPERIMENTAL
Intervention: Gow-Gates mandibular block (GGMB)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Inferior alveolar nerve block (IANB)
Number of subjects: 162
Study: 14629843

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 98
Study: 12118835

Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO+)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO-)
Number of subjects: 20

Group type: COMPARATOR
Intervention: EPO-
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Hemodialysis (HD) using H and PS membranes
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: EPO+ and EPO-
Number of subjects: 20
Study: 9361169

Group type: EXPERIMENTAL
Intervention: Nocloprost
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ranitidine
Number of subjects: 40